Company / Revenue
ANAPTYSBIO, INC Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$234.6M
FY2025
5-year range
$8.0M / $234.6M
FY2021-FY2025
Trend
+157.0%
vs FY2024
Sector context
#88 of 155
Health Care
What the data says
At $235M, ANAPTYSBIO, INC's revenue ranks #88 of 155 in the Health Care sector. Revenue has fluctuated over the past 10 years, ranging from $5M in FY2020 to $235M in FY2025.
Based on SEC 10-K filings.
$235M in FY2025 with a 5-year CAGR of +115.9%.
Improved from $17M to $235M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +46.2%
- 5-Year CAGR
- +115.9%
- 10-Year CAGR
- -
Sector benchmark
#88 of 155 in Health CareTop 57% of 155This company $234.6M Sector average $4.5B
▼
-94.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +115.9%, indicating consistent growth.
- In FY2025, revenue increased 157.0% year-over-year.
- Ranks #88 out of 155 companies in the Health Care sector.
- Lowest revenue in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $234.6M | +157.0% |
| FY2024 | $91.3M | +432.0% |
| FY2023 | $17.2M | -77.1% |
| FY2022 | $75.0M | +837.5% |
| FY2021 | $8.0M | +60.0% |
| FY2020 | $5.0M | -50.0% |
| FY2019 | $10.0M | +100.0% |
| FY2018 | $5.0M | -71.5% |
| FY2017 | $17.6M | +5.3% |
| FY2016 | $16.7M | -5.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026